125 related articles for article (PubMed ID: 10680919)
1. Radiation dose to otologic structures during head and neck cancer radiation therapy.
Ondrey FG; Greig JR; Herscher L
Laryngoscope; 2000 Feb; 110(2 Pt 1):217-21. PubMed ID: 10680919
[TBL] [Abstract][Full Text] [Related]
2. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
4. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
[TBL] [Abstract][Full Text] [Related]
7. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
8. Effect of radiotherapy on retro-cochlear auditory pathways.
Low WK; Burgess R; Fong KW; Wang DY
Laryngoscope; 2005 Oct; 115(10):1823-6. PubMed ID: 16222203
[TBL] [Abstract][Full Text] [Related]
9. Incidence of long-term ipsilateral and contralateral ototoxicity following radiotherapy for nasopharyngeal carcinoma.
Wakisaka H; Yamada H; Motoyoshi K; Ugumori T; Takahashi H; Hyodo M
Auris Nasus Larynx; 2011 Feb; 38(1):95-100. PubMed ID: 20541337
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
[TBL] [Abstract][Full Text] [Related]
11. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy.
Parliament M; Alidrisi M; Munroe M; Wolfaardt J; Scrimger R; Thompson H; Field C; Kurien E; Hanson J
Int J Oral Maxillofac Surg; 2005 Mar; 34(2):114-21. PubMed ID: 15695037
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity after radiotherapy for head and neck tumors.
Bhandare N; Antonelli PJ; Morris CG; Malayapa RS; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):469-79. PubMed ID: 17236969
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
[TBL] [Abstract][Full Text] [Related]
15. Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer.
Lee N; Mechalakos J; Puri DR; Hunt M
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1299-309. PubMed ID: 17241750
[TBL] [Abstract][Full Text] [Related]
16. Lightdosimetric quantitative analysis of the human petrous bone: experimental study for laser irradiation of the cochlea.
Tauber S; Baumgartner R; Schorn K; Beyer W
Lasers Surg Med; 2001; 28(1):18-26. PubMed ID: 11430438
[TBL] [Abstract][Full Text] [Related]
17. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
18. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
19. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
20. [Tolerance of normal tissues to radiation therapy: ear].
Fleury B; Lapeyre M
Cancer Radiother; 2010 Jul; 14(4-5):284-9. PubMed ID: 20605506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
